Covidien Nellcor™ OxySoft™ Neonatal-Adult SpO2 Sensor - HSA Registration DE0507227
Access comprehensive regulatory information for Covidien Nellcor™ OxySoft™ Neonatal-Adult SpO2 Sensor in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0507227 and owned by Covidien llc. The device was registered on September 01, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Nellcor™ OxySoft™ Neonatal-Adult SpO2 Sensor is intended for use in non-invasive continuous or spot-check monitoring of functional oxygen saturation of arterial oxygen saturation (SpO2) and pulse rate for neonates and infants weighing less than 3 kg or adults and pediatrics weighing more than 40 kg. It is indicated for use during both no motion and motion conditions and for patients who are either well or poorly perfused, in hospitals, hospital-type facilities, intra- hospital transport, mobile emergency medical applications including both ground and air transport and home environments.